BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)

$0.2448 0.0073 (3.0737%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 64

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) News Sources

bioAffinity Technologies Announces Notification of Japanese Patent Allowance Covering Noninvasive CyPath® Lung and AI-Built Algorithm

08-10-2026

yahoo.com

bioAffinity Technologies Receives Japanese Patent Allowance for CyPath Lung AI Diagnostic Test

08-10-2026

advfn.com

bioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

08-10-2026

yahoo.com

WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

08-10-2026

yahoo.com

bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

09-10-2026

yahoo.com

WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

09-10-2026

yahoo.com

bioAffinity Technologies to Present Positive Research Data in Development of Its New Test Measuring Asthma and COPD-Related Lung Inflammation and Drug-Related Receptors at CHEST 2026

13-10-2026

yahoo.com

bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026

15-10-2026

yahoo.com

bioAffinity Technologies expands Lung diagnostics pipeline into COPD and Asthma

27-10-2026

yahoo.com

bioAffinity Technologies Highlights Importance of Link Between Early Lung Cancer Detection and Curative Treatment During National Lung Cancer Awareness Month

29-10-2026

yahoo.com

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) Sentiment Trend

0 25 50 75 100 56 59 70 76 43 51 69 75 79 64 08-10-2026 09-10-2026 13-10-2026 15-10-2026 27-10-2026 29-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) FAQs

toggle

What is the current price of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?

The current price of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is $0.2448.


toggle

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) since the previous trading day is $0.0073.


toggle

BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) since the previous trading day is 3.0737%.


toggle

What is the most recent average sentiment score for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?

The most recent average sentiment score for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is 64 out of 100.


toggle

What is the most recent average sentiment for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)?

The most recent sentiment for BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ) is .


SEC-8K** Filing Available For BIOAFFINITY TECHNOLOGIEW-27 (BIAFW:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.